{ }
001122334455554433221100
001122334455554433221100

the evolving landscape of asset management in a digital age

Asset management is undergoing significant transformation driven by technological advancements, particularly artificial intelligence and blockchain, alongside rising demand for sustainable investments and stricter regulations. Experts highlight the growing importance of income-generating strategies and the rise of passive investments, while also noting the increasing relevance of alternative investments and personalized portfolios through robo-advisors. The landscape is evolving rapidly, necessitating adaptability to new market dynamics and regulatory frameworks.

Carmignac expands Board of Directors with six new appointments

Carmignac has appointed six new members to its Board of Directors, including former UBS executive Paolo Federici, who previously led UBS Global Wealth Management in Italy. Other notable appointees include Alexander Leisten, Habib Achkar, Pascale Guillier, Rose Ouahba, and Christophe Peronin, enhancing the firm's leadership and expertise.
08:49 18.10.2024

Carmignac appoints six new board members including former UBS executive

Carmignac has appointed six new members to its Board of Directors, including former UBS executive Paolo Federici, who previously led UBS Global Wealth Management in Italy. Other notable additions include Alexander Leisten from Fidelity International and Habib Achkar, a veteran of Morgan Stanley. This move aims to enhance the company's Supervisory Board, which is led by founder Edouard Carmignac.
06:28 17.10.2024

Carmignac expands board with six new members including former UBS executive

Carmignac has appointed six new members to its Board of Directors, including former UBS executive Paolo Federici, who previously led UBS Global Wealth Management in Italy. Other notable appointees include Alexander Leisten, Habib Achkar, Pascale Guillier, Rose Ouahba, and Christophe Peronin, enhancing the firm's leadership and expertise.

investing in oncology five reasons for growth and opportunity

Investors are increasingly drawn to oncology shares due to their defensive nature and potential for double-digit growth, driven by a significant unmet medical need and a robust pipeline of new treatments. The sector is also witnessing a surge in mergers and acquisitions, enhancing its strategic value. With favorable valuations and a growing demand for effective cancer therapies, the oncology market presents a compelling opportunity for long-term investment.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.